Clinical Trial Update: A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study" [NA]

View source ↗

Summary

This completed clinical trial evaluated pharmacogenetic factors affecting warfarin dosing in patients with atrial fibrillation, deep vein thrombosis, or pulmona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Deep Vein Thrombosis
• Pulmonary Embolism

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Atrial Fibrillation, Deep Vein Thrombosis | NA | Status: COMPLETED